Literature DB >> 335246

Antibodies to oligodendroglia in patients with multiple sclerosis.

O Abramsky, R P Lisak, D H Silberberg, D E Pleasure.   

Abstract

We demonstrated antibodies to isolated oligodendrocytes and to oligodendroglia in brain sections by indirect immunofluorescence technic in serums of 19 of 21 patients with multiple sclerosis. We also found such antibodies in three of five patients with subacute sclerosing panencephalitis and one of four patients with acute disseminated encephalomyelitis, but not in patients with other neurologic diseases or normal persons. The antibodies were absorbed by preincubation of serum with isolated oligodendrocytes or whole white matter, but not with purified myelin or liver tissue. Immunofluorescent staining was blocked by either rabbit anti-oligodendrocyte serum or non-fluoresceinated goat anti-human immunoglobulin. These findings suggest that antibodies to oligodendroglia are distinct from antibodies to myelin and that demyelination in multiple sclerosis could be a consequence of an immunopathologic reaction directed against oligodendroglial cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 335246     DOI: 10.1056/NEJM197712012972204

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  18 in total

1.  Circulating antibodies to peripheral nerve in American trypanosomiasis (Chagas' disease).

Authors:  E L Khoury; V Ritacco; P M Cossio; R P Laguens; A Szarfman; C Diez; R M Arana
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

2.  IgG synthesis within the brain in multiple sclerosis and subacute sclerosing panencephalitis.

Authors:  P W Ewan; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

3.  Abnormal protein patterns in multiple sclerosis.

Authors:  J Y Wu; K M Welch; C C Duncan
Journal:  Neurochem Res       Date:  1979-12       Impact factor: 3.996

Review 4.  Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE).

Authors:  R A Asherson; S D Denburg; J A Denburg; R M Carbotte; N Futrell
Journal:  Postgrad Med J       Date:  1993-08       Impact factor: 2.401

Review 5.  A review of the etiology of multiple sclerosis.

Authors:  V Vella
Journal:  Ital J Neurol Sci       Date:  1984-12

6.  Lymphocytotoxic antibody in multiple sclerosis: activity against T cell subsets and correlation with disease activity.

Authors:  C F Scott; L E Spitler
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

7.  Immunoglobulin G from subacute sclerosing panencephalitis brain as an immunological reagent.

Authors:  M L Weil; E Norrby; H H Itabashi; R Wilson; W W Tourtellotte; D C Heiner
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

8.  Serum antibodies to central nervous system antigens: an analysis of their relation with different human neurologic disorders.

Authors:  P Huppi; L Bologa; N Herschkowitz
Journal:  Neurochem Res       Date:  1987-07       Impact factor: 3.996

9.  Antibody to myelin basic protein in extracts of multiple sclerosis brain.

Authors:  C C Bernard; V B Randell; L B Horvath; P R Carnegie; I R Mackay
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

10.  Beta-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients.

Authors:  H Ohguro; S Chiba; Y Igarashi; H Matsumoto; T Akino; K Palczewski
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.